Abeona Therapeutics, Inc. (ABEO)
5.49
+0.13
(+2.43%)
USD |
NASDAQ |
Jun 11, 13:31
Abeona Therapeutics Total Liabilities (Quarterly) : 53.56M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 53.56M |
| December 31, 2025 | 61.96M |
| September 30, 2025 | 59.86M |
| June 30, 2025 | 82.66M |
| March 31, 2025 | 57.97M |
| December 31, 2024 | 64.90M |
| September 30, 2024 | 74.82M |
| June 30, 2024 | 60.76M |
| March 31, 2024 | 83.71M |
| December 31, 2023 | 49.18M |
| September 30, 2023 | 44.05M |
| June 30, 2023 | 44.20M |
| March 31, 2023 | 34.60M |
| December 31, 2022 | 37.45M |
| September 30, 2022 | 23.35M |
| June 30, 2022 | 24.63M |
| March 31, 2022 | 23.73M |
| December 31, 2021 | 28.21M |
| September 30, 2021 | 39.28M |
| June 30, 2021 | 46.59M |
| March 31, 2021 | 47.04M |
| December 31, 2020 | 48.65M |
| September 30, 2020 | 44.25M |
| June 30, 2020 | 43.32M |
| March 31, 2020 | 42.63M |
| Date | Value |
|---|---|
| December 31, 2019 | 44.95M |
| September 30, 2019 | 46.72M |
| June 30, 2019 | 52.25M |
| March 31, 2019 | 48.34M |
| December 31, 2018 | |
| September 30, 2018 | 10.33M |
| June 30, 2018 | 5.783M |
| March 31, 2018 | 6.454M |
| December 31, 2017 | 8.668M |
| September 30, 2017 | 5.851M |
| June 30, 2017 | 7.581M |
| March 31, 2017 | 9.578M |
| December 31, 2016 | 11.96M |
| September 30, 2016 | 10.33M |
| June 30, 2016 | 12.67M |
| March 31, 2016 | 11.76M |
| December 31, 2015 | 12.33M |
| September 30, 2015 | 16.48M |
| June 30, 2015 | 16.98M |
| March 31, 2015 | 9.958M |
| December 31, 2014 | 11.77M |
| September 30, 2014 | 30.64M |
| June 30, 2014 | 28.64M |
| March 31, 2014 | 15.97M |
| December 31, 2013 | 15.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 176.89M |
| Forum Markets, Inc. | 39.28M |
| Precigen, Inc. | 118.39M |
| PDS Biotechnology Corp. | 20.77M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 198.49M |
| Shareholders Equity (Quarterly) | 144.94M |
| Debt to Equity Ratio | 0.1599 |
| Current Ratio | 5.894 |
| Net Debt Paydown Yield | -0.01% |